Synonym
FRC-8653; FRC 8653; FRC8653; Cilnidipine; Atelec; Cinalong; Siscard.
IUPAC/Chemical Name
(E)-Cinnamyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
InChi Key
KJEBULYHNRNJTE-DHZHZOJOSA-N
InChi Code
InChI=1S/C27H28N2O7/c1-18-23(26(30)35-14-8-11-20-9-5-4-6-10-20)25(21-12-7-13-22(17-21)29(32)33)24(19(2)28-18)27(31)36-16-15-34-3/h4-13,17,25,28H,14-16H2,1-3H3/b11-8+
SMILES Code
O=C(C1=C(C)NC(C)=C(C(OC/C=C/C2=CC=CC=C2)=O)C1C3=CC=CC([N+]([O-])=O)=C3)OCCOC
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
492.53
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kuwahara K, Kimura T. The organ-protective effect of N-type Ca(2+) channel blockade. Pharmacol Ther. 2015 Jul;151:1-7. doi: 10.1016/j.pharmthera.2015.02.001. Epub 2015 Feb 7. Review. PubMed PMID: 25659931.
2: Ando K. L-/N-type calcium channel blockers and proteinuria. Curr Hypertens Rev. 2013 Aug;9(3):210-8. Review. PubMed PMID: 24479751.
3: Homma K, Hayashi K, Yamaguchi S, Fujishima S, Hori S, Itoh H. Renal microcirculation and calcium channel subtypes. Curr Hypertens Rev. 2013 Aug;9(3):182-6. Review. PubMed PMID: 24479750; PubMed Central PMCID: PMC4033552.
4: Chandra KS, Ramesh G. The fourth-generation Calcium channel blocker: cilnidipine. Indian Heart J. 2013 Dec;65(6):691-5. doi: 10.1016/j.ihj.2013.11.001. Review. PubMed PMID: 24407539; PubMed Central PMCID: PMC3905258.
5: Xu G, Wu H, Du B, Qin L. The efficacy and safety of cilnidipine on mild to moderate essential hypertension: a systematic review and meta-analysis of randomized controlled trials in Chinese patients. Cardiovasc Hematol Disord Drug Targets. 2012 Sep;12(1):56-62. Review. PubMed PMID: 22746347.
6: Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, Itoh H. T-type Ca channel blockade as a determinant of kidney protection. Keio J Med. 2010;59(3):84-95. Review. PubMed PMID: 20881449.
7: Ito Y, Araki N. [Calcium antagonists: current and future applications based on new evidence. Neuroprotective effect of calcium antagonists]. Clin Calcium. 2010 Jan;20(1):83-8. doi: CliCa10018388. Review. Japanese. PubMed PMID: 20048438.
8: Mizuta E, Hamada T, Igawa O, Shigemasa C, Hisatome I. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers]. Clin Calcium. 2010 Jan;20(1):45-50. doi: CliCa10014550. Review. Japanese. PubMed PMID: 20048433.
9: Hirooka Y, Sunagawa K. [Calcium antagonists: current and future applications based on new evidence. Calcium channel blockers and autonomic nervous system]. Clin Calcium. 2010 Jan;20(1):32-7. doi: CliCa10013237. Review. Japanese. PubMed PMID: 20048431.
10: Takahara A. Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release. Cardiovasc Ther. 2009 Summer;27(2):124-39. doi: 10.1111/j.1755-5922.2009.00079.x. Review. PubMed PMID: 19426250.
11: Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res. 2007 Feb 16;100(3):342-53. Review. PubMed PMID: 17307972.
12: Hermida RC, Smolensky MH. Chronotherapy of hypertension. Curr Opin Nephrol Hypertens. 2004 Sep;13(5):501-5. Review. PubMed PMID: 15300155.
13: Suzuki H, Kanno Y. [Diagnosis of and therapy for renal hypertension]. Nihon Naika Gakkai Zasshi. 2004 Mar 10;93(3):488-92. Review. Japanese. PubMed PMID: 15052808.
14: Uneyama H, Takahara A, Wakamori M, Mori Y, Yoshimoto R. Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review). Int J Mol Med. 1999 May;3(5):455-66. Review. PubMed PMID: 10202175.
15: Saruta T. Current status of calcium antagonists in Japan. Am J Cardiol. 1998 Nov 12;82(9B):32R-34R. Review. PubMed PMID: 9822142.
